Determination of transcutaneous oxygen tension for evaluating the degree of ischemia in patients with diabetic foot syndrome
Keywordsdiabetic foot syndrome, transcutaneous oxygen tension, diabetes mellitus, revascularization
One of the main syndromes that poses a direct threat to the patient's ability to work and life is diabetic foot syndrome (DFS). It is known that DFS is caused by a complex of disorders of the anatomical and functional state of the foot due to neuro-ischemic changes caused by prolonged hyperglycemia. The aim of styding was to investigate the value of transcutaneous oxygen tension during the performance of revascularization and rehabilitation interventions in patients with DFS. We studied 114 patients with purulent-necrotic forms of DFS with moderate and severe diabetes, who were determined by the value of transcutaneous oxygen tension during hospital treatment.
Therefore, determination of transcutaneous oxygen tension is the most informative way to assess the degree of ischemia before and after revascularization operations. When the value of TcpO2 at the foot ≤25 mmHg we recommend performing the first stage of revascularization intervention. At TcPO2 values >25 mmHg, revascularization was recommended for post-primary remediation of purulent-necrotic lesions and to accelerate healing in patients with large foot tissue defects after surgery for purulent-necrotic complications of DFS. When restoring the value of the transcutaneous voltage above25 mmHg it can be performed remediation interventions at almost any distal level. At values of 10-25 mmHg – it should be done more proximal level (where the determined transcutaneous value of TcpO2 is about 15-25 mmHg) of the demarcation line necrosis, as the risk of reamputation is higher than 75 %. At values of ≤10 mmHg, we recommend performing high amputations.
Lim JZ, Ng NS, Thomas C. Prevention and treatment of diabetic foot ulcers. J R Soc Med. 2017; 110(3):104-109. doi: 10.1177/0141076816688346.
Volmer-Thole M, Lobmann R. Neuropathy and Diabetic Foot Syndrome. Int J Mol Sci. 2016; 17(6): 917. doi: 10.3390/ijms17060917.
Bus SA. The Role of Pressure Offloading on Diabetic Foot Ulcer Healing and Prevention of Recurrence. Plast Reconstr Surg. 2016; 138 (3 Suppl):179S-87S. doi: 10.1097/PRS.0000000000002686.
Ahmad J. The diabetic foot. Diabetes Metab Syndr. 2016; 10(1): 48-60. doi: 10.1016/j.dsx.2015.04.002.
Ghotaslou R, Memar MY, Alizadeh N. Classification, microbiology and treatment of diabetic foot infections. J Wound Care. 2018; 27(7): 434-441. doi: 10.12968/jowc.2018.27.7.434.
Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018; 1411(1): 153-165. doi: 10.1111/nyas.13569.
Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 Jun;54(12):e132-73. doi: 10.1093/cid/cis346.
Noor S, Khan RU, Ahmad J. Understanding Diabetic Foot Infection and its Management. Diabetes Metab Syndr. 2017; 11(2): 149-156. doi: 10.1016/j.dsx.2016.06.023.
Chastain CA, Klopfenstein N, Serezani CH, Aronoff DM. A Clinical Review of Diabetic Foot Infections. Clin Podiatr Med Surg. 2019; 36(3): 381-395. doi: 10.1016/j.cpm.2019.02.004.
Game F. Classification of diabetic foot ulcers. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:186-94. doi: 10.1002/dmrr.2746.
Ndosi M, Wright-Hughes A, Brown S, Backhouse M, Lipsky BA et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018; 35(1):78-88. doi: 10.1111/dme.13537.
Hurlow JJ, Humphreys GJ, Bowling FL, McBain AJ. Diabetic foot infection: A critical complication. Int Wound J. 2018; 15(5): 814-821. doi: 10.1111/iwj.12932.
Spanos K, Saleptsis V, Athanasoulas A, Karathanos C, Bargiota A et al. Factors Associated With Ulcer Healing and Quality of Life in Patients With Diabetic Foot Ulcer. Angiology. 2017; 68(3): 242-250. doi: 10.1177/0003319716651166.
Aragón-Sánchez J, Lipsky BA. Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches. Expert Rev Anti Infect Ther. 2018 Jan;16(1):35-50. doi: 10.1080/14787210.2018.1417037.
Schmidt BM, Holmes CM. Updates on Diabetic Foot and Charcot Osteopathic Arthropathy. Curr Diab Rep. 2018; 18(10): 74. doi: 10.1007/s11892-018-1047-8.
Bravo-Molina A, Linares-Palomino JP, Vera-Arroyo B, Salmerón-Febres LM, Ros-Díe E. Inter-observer agreement of the Wagner, University of Texas and PEDIS classification systems for the diabetic foot syndrome. Foot Ankle Surg. 2018; 24(1): 60-64. doi: 10.1016/j.fas.2016.10.009.
How to Cite
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 221
Number of citations: 0